Biopharma | May 06, 2026
Emcure crosses US$1 billion revenue milestone in FY26; PAT rises 33%
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
The kidney care provider has established over 40 dialysis centres, delivering more than 40,000 dialysis sessions
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
The private funding rose 38% amid growing international collaborations and CDMO demand
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Report highlights growing confidence in digitalisation and AI, even as healthcare leaders remain concerned about workforce gaps, cybersecurity, and data readiness
Discussions focused on digital health, non-communicable diseases, resilient supply chains, medical innovation, and healthcare workforce development
India’s largest life sciences entrepreneurship competition opens applications for startups, innovators and student teams nationwide
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
The initiative pairs consumer engagement with a public health message about prevention and early detection
Subscribe To Our Newsletter & Stay Updated
